Andere talen Imricor Medical Systems, Inc.

Aandelen

IMR

AU0000054942

Vertraagde tijd Australian S.E. Andere beurzen 08:10:49 11-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,45 ^AUD	+1,12%		-4,26%	-21,05%

15/05	Imricor Medical Systems, Inc. start 2 klinische onderzoeken, VISABL-AFL en VISABL-VT	CI
15/05	Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Imricor Medical Systems, Inc. to Commence 2 Clinical Trials, VISABL-AFL and VISABL-VT	15/05
Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic	09/05
Imricor Medical Systems Announces Release of Certain Stocks from Voluntary Escrow	02/05
Imricor Medical Systems Secures First Catheter Order from Croatia's Dubrava University Hospital	11/04
Mining, Healthcare Stocks Lift Australian Benchmark	10/04
Imricor Medical Systems Gains Approval for Clinical Trial at Cardiovascular Institute of South Paris; Shares Up 7%	10/04
Amsterdam University Medical Center Resumes Atrial Flutter Procedures with Imricor's NorthStar Mapping System	05/04
Imricor Medical Systems Completes AU$6.4 Million Shortfall Share Issue	02/04
Imricor Medical Systems' NorthStar 3D Mapping System Obtains Approval for Use in VISABL-AFL Trial	26/03
Imricor Medical Systems Secures Ethics Approval for Imaging Device Trial; Shares Rise 4%	11/03
Imricor Medical Systems' VISABL-AFL Trial Obtains Lausanne University Hospital Ethics Approval; Shares Up 8%	08/03
Imricor's Diagnostic Catheter Granted CE Mark Approval for European Market Sales; Shares Decline 4%	06/03
Imricor Medical Systems' Loss Widens in 2023; Shares Down 8%	29/02
Imricor Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Imricor Medical Systems Plans Up to AU$15 Million Placement, Entitlement Offer	02/02
Imricor Medical Systems Secures Approval to Start US Medical Device Trial	18/01
Imricor Gets Approval from Saudi Food and Drug Authority for ICMR Cardiac Ablation Products	11/01
Imricor Medical Systems Signs Distribution Agreement with Qatar's East Agency WWL	20/12
Imricor Medical Systems Signs Deal to Incorporate AI Modules to Heart Mapping System	28/11
Imricor Medical Raises AU$4.3 Million from Share Placement	25-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Imricor Medical Systems, Inc.

Aandelen

IMR

AU0000054942

Andere talen

Filters